Skip to content

The Role of Blood Flow Restriction Therapy in Postop Rehabilitation of Foot and Ankle Injuries

The Role of Blood Flow Restriction Therapy in Postop Rehabilitation of Foot and Ankle Injuries

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05844280
Enrollment
0
Registered
2023-05-06
Start date
2026-08-31
Completion date
2029-12-31
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture of Foot

Brief summary

The purpose of the study is to determine the role of blood flow restriction (BFR) + neuromuscular electrical stimulation (NMES) in improving post-operative physical therapy and recovery after ankle fracture surgery. We expect to see improved muscle strength, less muscle wasting, and improved functional recovery after surgery when making these additions to routine post-operative (postop) physical therapy protocols.

Detailed description

Few studies have examined BFR in patients sustaining operative foot and ankle injuries. Due to the weight bearing limitations and prolonged immobilization following these injuries, patients often experience increased time away from work and delays with return to sport. These factors are responsible for the rapid muscle atrophy that occurs in the immediate post injury period because of immobility and disuse. Recently, blood flow restriction (BFR) therapy has been shown to be effective in improving muscle strength and preventing atrophy when combined with low load resistance training physical therapy programs.7,8 Neuromuscular electrical stimulation (NMES) is an adjunctive agent that has been show to augment the effects of BFR alone.4 The null hypothesis is that a 2 week BFR + NMES + low load resistance training program in patients age \>= 18 recovering from foot and ankle surgery will have no effect on short term (2 weeks postop) lower extremity muscle hypertrophy or atrophy, patient pain and satisfaction, or functional recovery after foot and ankle surgery.

Interventions

PROCEDUREBFR+NMES at therapeutic level

This group will receive therapy with BFR+NMES devices used at settings that are deemed by prior studies to be therapeutic.

PROCEDUREBFR+NMES at sub therapeutic level

This means that the BFR tourniquet and the NMES device will be at such low settings as to not create the treatment effect but subject will have the equipments on their thigh during exercise

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* isolated, closed low-energy rotational ankle fracture without prior surgery or implants to injured area

Exclusion criteria

* history of Deep Vein Thrombosis in affected extremity * history of significant cardiac disease defined as a recent stent placement in past * history of peripheral arterial disease * history of sickle cell disease * history of coagulopathy * presenting to surgery \>14 days after injury

Design outcomes

Primary

MeasureTime frameDescription
Assess for calf muscle atrophy as measured by calf circumference2 weeks postopCalf circumference will be measured using a measuring tape
Assess for calf muscle atrophy as measured by hand held dynamometry2 weeks postopHand held Dynamometry will be used to measure the length-tension relationship of the muscle in pounds

Secondary

MeasureTime frameDescription
Patient tolerance of the BFR treatment using the Visual Analogue Pain Scale.2 weeks postopThe Visual Analogue Pain Scale is used during the beginning, midpoint, and end of a session. This scale ranges from 0-10 which 0 being no pain and 10 being worst pain
Patient tolerance of the BFR treatment using the the Borg Rating of Perceived Exertion f2 weeks postopThe Borg Rating of Perceived Exertion will be used for each session and exercise. This rating ranges from 6-20 with 6 being no exertion at all, and 20 being maximum effort

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026